Infection Prevention

Latest Issue of OR Manager
February 2021
Home Periop Nursing > Perioperative Practice > Infection Prevention

J&J’s single-dose COVID-19 vaccine has good safety profile

Editor's Note Results from Johnson & Johnson’s early-stage trials for its COVID-19 vaccine showed neutralizing antibodies in all participants who received the vaccine when they were tested at 57 days. The J&J Ad26.COV2.S vaccine is different than the Pfizer-BioNTech and Moderna vaccines in that it is anenovirus-based rather than mRNA-based.…

Read More

By: Judy Mathias
January 19, 2021
Share

Parsing COVID-19 transmission routes informs levels of protection needed

Information about COVID-19 transmission and treatment has evolved between the time this infectious disease first emerged and now. As evidence-based knowledge grows and protocols change, and as populations are vaccinated to develop herd immunity, there is increasing optimism about the ability to combat the virus. Meanwhile, it is important to…

Read More

By: Judith M. Mathias, MA, RN
January 19, 2021
Share

Supply chain strategies shift to meet pandemic-induced demands

Resiliency, a term that has cropped up repeatedly during the COVID-19 pandemic, is often considered a key defense against burnout. But it is also important in the context of the healthcare supply chain, says Ed Hisscock, senior vice president of supply chain management at Trinity Health, a 22-state healthcare system…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Sponsored Message

Editorial

The rollout of COVID-19 vaccines starting in December 2020 was the one bright spot in an otherwise tragic year with a rapidly rising death toll currently over 385,000. Distribution of the 20 million doses promised by year end was thwarted by problems such as lack of coordination and lack of…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Expanding reprocessing programs can yield cost savings

The financial impact of COVID-19 on healthcare providers has been considerable. With experts predicting that half of all US hospitals would be operating in the red by the end of 2020, healthcare leaders have had to seek multiple ways to cut costs. The expansion of single-use medical device (SUD) reprocessing…

Read More

By: OR Manager
January 19, 2021
Share

New year brings some changes to quality reporting criteria

The 2021 Medicare Hospital Outpatient Prospective Payment System (OPPS)/ASC Final Payment Rule was released on December 1, 2020, and became effective as of January 1, 2021. Gina Throneberry, MBA, RN, CASC, CNOR, director of education and clinical affairs, Ambulatory Surgery Center Association (ASCA), summarized the status of Medicare regulations and…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Sponsored Message

COVID-19 incidence, secondary transmission in schools

Editor's Note This study led by researchers from Duke University School of Medicine, Durham, North Carolina, finds that in the first 9 weeks of in-person classes in North Carolina schools, there was extremely limited within-school secondary transmissions of COVID-19. The researchers examined 11 school districts with more than 90,000 students…

Read More

By: Judy Mathias
January 14, 2021
Share

CDC expands requirement for negative COVID-19 test to all airline passengers entering US

Editor's Note Centers for Disease Control and Prevention (CDC) Director Robert R. Redfield, MD, on January 12, signed an order to expand the requirement for a negative COVID-19 test to all airline passengers entering the US. The order, which will become effective January 26, requires that: Airline passengers get a…

Read More

By: Judy Mathias
January 14, 2021
Share

CDC: COVID-19 trends in individuals aged 0-24 years

Editor's Note This study by researchers from the Centers for Disease Control and Prevention (CDC) finds that COVID-19 cases in children, adolescents, and young adults increased during the review period (March 1-December 12), with spikes in early summer, followed by a decline, and then a steep increase from October through…

Read More

By: Judy Mathias
January 14, 2021
Share

Protective immunity against COVID-19 could last 8 months or more

Editor's Note This study led by researchers from the Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, finds that response to COVID-19 by the immune system can last for at least 8 months after the onset of symptoms. The researchers measured antibodies, memory…

Read More

By: Judy Mathias
January 12, 2021
Share

Get OR Manager Updates

Sign Up Now
Video Spotlight
OR Manager Jobs
Live chat by BoldChat